会員登録
ログイン
【4547】キッセイ薬品工業
製薬。排尿改善薬、糖尿病薬など。
業績予想修正履歴
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024.03 | 2024/01/30 | Q3予 | 77,500 | → | 0.0% | +4.0% | 5,000 | → | 0.0% | +19.0% | 6,700 | → | 0.0% | +28.8% | 10,000 | → | 0.0% | -5.7% |
| 2024.03 | 2023/11/06 | Q2予 | 77,500 | ↑ | +4.0% | +4.0% | 5,000 | ↑ | +19.0% | +19.0% | 6,700 | ↑ | +28.8% | +28.8% | 10,000 | ↓ | -5.7% | -5.7% |
| 2024.03 | 2023/07/31 | Q1予 | 74,500 | → | 0.0% | 0.0% | 4,200 | → | 0.0% | 0.0% | 5,200 | → | 0.0% | 0.0% | 10,600 | → | 0.0% | 0.0% |
| 2024.03 | 2023/05/08 | 当初予 | 74,500 | - | - | - | 4,200 | - | - | - | 5,200 | - | - | - | 10,600 | - | - | - |
| 2023.03 | 2023/05/08 | 実 | 67,493 | ↑ | +0.1% | -0.7% | -1,129 | ↑ | +5.9% | -140.3% | 598 | ↑ | +19.6% | -86.4% | 10,528 | ↑ | +0.3% | +5.3% |
| 2023.03 | 2023/04/21 | 修正予 | 67,400 | ↓ | -1.6% | -0.9% | -1,200 | ↓ | -340.0% | -142.9% | 500 | ↓ | -76.2% | -88.6% | 10,500 | ↓ | -2.8% | +5.0% |
| 2023.03 | 2023/01/31 | Q3予 | 68,500 | → | 0.0% | +0.7% | 500 | → | 0.0% | -82.1% | 2,100 | → | 0.0% | -52.3% | 10,800 | → | 0.0% | +8.0% |
| 2023.03 | 2022/11/08 | Q2予 | 68,500 | ↑ | +0.7% | +0.7% | 500 | ↓ | -82.1% | -82.1% | 2,100 | ↓ | -52.3% | -52.3% | 10,800 | ↑ | +8.0% | +8.0% |
| 2023.03 | 2022/08/01 | Q1予 | 68,000 | → | 0.0% | 0.0% | 2,800 | → | 0.0% | 0.0% | 4,400 | → | 0.0% | 0.0% | 10,000 | → | 0.0% | 0.0% |
| 2023.03 | 2022/05/10 | 当初予 | 68,000 | - | - | - | 2,800 | - | - | - | 4,400 | - | - | - | 10,000 | - | - | - |
| 2022.03 | 2022/05/10 | 実 | 65,381 | ↑ | +0.1% | +3.0% | -1,402 | ↓ | -0.1% | +46.1% | 562 | ↑ | +12.4% | +143.2% | 12,921 | ↑ | +0.2% | +291.5% |
| 2022.03 | 2022/04/22 | 修正予 | 65,300 | ↓ | -0.2% | +2.8% | -1,400 | ↑ | +12.5% | +46.2% | 500 | ↑ | +66.7% | +138.5% | 12,900 | ↑ | +8.4% | +290.9% |
| 2022.03 | 2022/02/01 | Q3予 | 65,400 | → | 0.0% | +3.0% | -1,600 | → | 0.0% | +38.5% | 300 | → | 0.0% | +123.1% | 11,900 | → | 0.0% | +260.6% |
| 2022.03 | 2021/11/09 | Q2予 | 65,400 | ↑ | +3.0% | +3.0% | -1,600 | ↑ | +38.5% | +38.5% | 300 | ↑ | +123.1% | +123.1% | 11,900 | ↑ | +260.6% | +260.6% |
| 2022.03 | 2021/08/02 | Q1予 | 63,500 | → | 0.0% | 0.0% | -2,600 | → | 0.0% | 0.0% | -1,300 | → | 0.0% | 0.0% | 3,300 | → | 0.0% | 0.0% |
| 2022.03 | 2021/05/11 | 当初予 | 63,500 | - | - | - | -2,600 | - | - | - | -1,300 | - | - | - | 3,300 | - | - | - |
| 2021.03 | 2021/05/11 | 実 | 69,044 | ↑ | +0.1% | +5.4% | 1,505 | ↑ | +0.3% | +132.7% | 3,476 | ↑ | +2.2% | +205.3% | 5,285 | ↑ | +1.6% | +70.5% |
| 2021.03 | 2021/04/23 | 修正予 | 69,000 | ↑ | +1.5% | +5.3% | 1,500 | ↑ | +87.5% | +132.6% | 3,400 | ↑ | +61.9% | +203.0% | 5,200 | ↑ | +13.0% | +67.7% |
| 2021.03 | 2021/02/01 | Q3予 | 68,000 | → | 0.0% | +3.8% | 800 | → | 0.0% | +117.4% | 2,100 | → | 0.0% | +163.6% | 4,600 | → | 0.0% | +48.4% |
| 2021.03 | 2020/11/05 | Q2予 | 68,000 | ↑ | +3.8% | +3.8% | 800 | ↑ | +117.4% | +117.4% | 2,100 | ↑ | +163.6% | +163.6% | 4,600 | ↑ | +48.4% | +48.4% |
| 2021.03 | 2020/08/03 | Q1予 | 65,500 | → | 0.0% | 0.0% | -4,600 | → | 0.0% | 0.0% | -3,300 | → | 0.0% | 0.0% | 3,100 | → | 0.0% | 0.0% |
| 2021.03 | 2020/05/12 | 当初予 | 65,500 | - | - | - | -4,600 | - | - | - | -3,300 | - | - | - | 3,100 | - | - | - |
| 2020.03 | 2020/05/12 | 実 | 63,234 | ↑ | +2.0% | +3.0% | 1,857 | ↑ | +23.8% | +85.7% | 2,429 | ↓ | -10.0% | +10.4% | 2,817 | ↓ | -2.9% | +4.3% |
| 2020.03 | 2020/01/31 | Q3予 | 62,000 | → | 0.0% | +1.0% | 1,500 | → | 0.0% | +50.0% | 2,700 | → | 0.0% | +22.7% | 2,900 | → | 0.0% | +7.4% |
| 2020.03 | 2019/11/06 | Q2予 | 62,000 | ↑ | +1.0% | +1.0% | 1,500 | ↑ | +50.0% | +50.0% | 2,700 | ↑ | +22.7% | +22.7% | 2,900 | ↑ | +7.4% | +7.4% |
| 2020.03 | 2019/07/30 | Q1予 | 61,400 | → | 0.0% | 0.0% | 1,000 | → | 0.0% | 0.0% | 2,200 | → | 0.0% | 0.0% | 2,700 | → | 0.0% | 0.0% |
| 2020.03 | 2019/05/08 | 当初予 | 61,400 | - | - | - | 1,000 | - | - | - | 2,200 | - | - | - | 2,700 | - | - | - |
| 2019.03 | 2019/05/08 | 実 | 72,297 | ↓ | -0.6% | +0.8% | 6,202 | ↓ | -3.1% | -21.5% | 7,169 | ↓ | -3.1% | -19.4% | 5,481 | ↓ | -0.3% | -17.0% |
| 2019.03 | 2019/02/01 | Q3予 | 72,700 | → | 0.0% | +1.4% | 6,400 | → | 0.0% | -19.0% | 7,400 | → | 0.0% | -16.9% | 5,500 | → | 0.0% | -16.7% |
| 2019.03 | 2018/11/06 | Q2予 | 72,700 | ↑ | +1.4% | +1.4% | 6,400 | ↓ | -19.0% | -19.0% | 7,400 | ↓ | -16.9% | -16.9% | 5,500 | ↓ | -16.7% | -16.7% |
| 2019.03 | 2018/07/31 | Q1予 | 71,700 | → | 0.0% | 0.0% | 7,900 | - | - | - | 8,900 | → | 0.0% | 0.0% | 6,600 | → | 0.0% | 0.0% |
| 2019.03 | 2018/05/08 | 当初予 | 71,700 | - | - | - | - | - | - | - | 8,900 | - | - | - | 6,600 | - | - | - |
| 2018.03 | 2018/05/08 | 実 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 2018.03 | 2018/01/31 | Q3予 | 75,000 | → | 0.0% | +2.5% | 9,500 | → | 0.0% | +5.6% | 11,100 | → | 0.0% | +11.0% | 8,600 | → | 0.0% | +10.3% |
| 2018.03 | 2017/11/07 | Q2予 | 75,000 | ↑ | +2.5% | +2.5% | 9,500 | ↑ | +5.6% | +5.6% | 11,100 | ↑ | +11.0% | +11.0% | 8,600 | ↑ | +10.3% | +10.3% |
| 2018.03 | 2017/08/01 | Q1予 | 73,200 | → | 0.0% | 0.0% | 9,000 | → | 0.0% | 0.0% | 10,000 | → | 0.0% | 0.0% | 7,800 | → | 0.0% | 0.0% |
| 2018.03 | 2017/05/09 | 当初予 | 73,200 | - | - | - | 9,000 | - | - | - | 10,000 | - | - | - | 7,800 | - | - | - |
| 2017.03 | 2017/05/09 | 実 | 71,706 | ↑ | +0.0% | +1.0% | 8,491 | ↓ | -7.7% | -1.3% | 9,638 | ↓ | -3.6% | +0.4% | 7,726 | ↑ | +0.3% | +10.4% |
| 2017.03 | 2017/01/31 | Q3予 | 71,700 | → | 0.0% | +1.0% | 9,200 | → | 0.0% | +7.0% | 10,000 | → | 0.0% | +4.2% | 7,700 | → | 0.0% | +10.0% |
| 2017.03 | 2016/11/08 | Q2予 | 71,700 | ↑ | +1.0% | +1.0% | 9,200 | ↑ | +7.0% | +7.0% | 10,000 | ↑ | +4.2% | +4.2% | 7,700 | ↑ | +10.0% | +10.0% |
| 2017.03 | 2016/07/29 | 当初予 | 71,000 | - | - | - | 8,600 | - | - | - | 9,600 | - | - | - | 7,000 | - | - | - |
| 2016.03 | 2016/05/11 | 実 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 2016.03 | 2016/02/01 | Q3予 | 71,700 | → | 0.0% | +1.7% | 10,000 | → | 0.0% | +14.9% | 10,800 | → | 0.0% | +14.9% | 7,900 | → | 0.0% | +16.2% |
| 2016.03 | 2015/11/04 | Q2予 | 71,700 | ↑ | +1.7% | +1.7% | 10,000 | ↑ | +14.9% | +14.9% | 10,800 | ↑ | +14.9% | +14.9% | 7,900 | ↑ | +16.2% | +16.2% |
| 2016.03 | 2015/08/03 | Q1予 | 70,500 | → | 0.0% | 0.0% | 8,700 | - | - | - | 9,400 | → | 0.0% | 0.0% | 6,800 | → | 0.0% | 0.0% |
| 2016.03 | 2015/05/12 | 当初予 | 70,500 | - | - | - | - | - | - | - | 9,400 | - | - | - | 6,800 | - | - | - |
| 2015.03 | 2015/05/12 | 実 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 2015.03 | 2015/02/02 | Q3予 | 68,700 | → | 0.0% | +2.2% | 9,400 | → | 0.0% | +20.5% | 10,900 | → | 0.0% | +25.3% | 7,740 | → | 0.0% | +26.9% |
| 2015.03 | 2014/11/05 | Q2予 | 68,700 | ↑ | +2.2% | +2.2% | 9,400 | ↑ | +20.5% | +20.5% | 10,900 | ↑ | +25.3% | +25.3% | 7,740 | ↑ | +26.9% | +26.9% |
| 2015.03 | 2014/08/01 | Q1予 | 67,200 | → | 0.0% | 0.0% | 7,800 | → | 0.0% | 0.0% | 8,700 | → | 0.0% | 0.0% | 6,100 | → | 0.0% | 0.0% |
| 2015.03 | 2014/05/08 | 当初予 | 67,200 | - | - | - | 7,800 | - | - | - | 8,700 | - | - | - | 6,100 | - | - | - |
| 2014.03 | 2014/05/08 | 実 | 70,399 | - | - | - | 12,301 | - | - | - | 13,541 | - | - | - | 9,093 | - | - | - |
